Apotex Pulls Antitrust Suit Vs. Allergan Over Acular Patent

Law360, New York (January 12, 2004, 12:00 AM EST) -- Apotex and Novex withdrew their antitrust lawsuit against Allergan and Roche Palo Alto after losing a patent infringement suit against Allergan last week.

The lawsuit had been pending in the U.S. District Court for the Northern District of California.

The lawsuit was based on allegations concerning a patent infringement action brought by Allergan and Syntex LLC against the Apotex defendants over their plans to launch a generic version of Allergan's non-steroidal anti-inflammatory drug Acular.

Last week, U.S. District Court Judge Martin Jenkins held that the patent...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.